Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,995 public trials 744 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)

NCT02123667

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Chiesi Clinical Trial Site #0503 Denver, Colorado, United States

Chiesi Clinical Trial Site #0502 Durham, North Carolina, United States

Chiesi Clinical Trial Site #0504 Cleveland, Ohio, United States

Chiesi Clinical Trial Site #0501 Houston, Texas, United States

View all 26 locations

View Trial Details

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001

NCT02386761

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Quotient Clinical Nottingham, UK, United Kingdom

View Trial Details

Completed

Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD

NCT03004417

Conditions: COPD, Chronic Disease, Disease Attributes, +6 more
Locations: Medicines Evaluation Unit Ltd Manchester, United Kingdom

View Trial Details

Completed

A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients.

NCT01191424

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Copenhagen University Hospital Copenhagen, Denmark

Medicines Evaluation Unit Manchester, United Kingdom

View Trial Details

Completed

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

NCT01703052

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations: Quotient Clinical Nottingham, United Kingdom

View Trial Details

Completed

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

NCT02991859

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Berlin, Germany

GSK Investigational Site Harrow, Middlesex, United Kingdom

GSK Investigational Site Manchester, United Kingdom

View Trial Details

Completed

Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients

NCT01803087

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Uniwersytecki Szpital Kliniczny nr 1 Lodz, Poland

View Trial Details

Completed

Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI

NCT01349257

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Medicines Evaluation Unit Ltd Manchester, United Kingdom

View Trial Details

Completed

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

NCT00742248

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: "Centro Dipartimentale di Fisiopatologia Respiratoria", University of Genoa Genova, Italy

View Trial Details

Completed

International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)

NCT01567280

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Azienda Sanitaria Firenze Piero Palagi Florence, Italy

View Trial Details

Lung Diseases, Obstructive

Lung Diseases, Obstructive trial results

Related conditions